Aclaris Therapeutics
ACRS
$1.19
Share price
0.00%
Change (1 day)
-85.80%
Change (1 year)
Categories
Aclaris Therapeutics (ACRS) - Cash on Hand
Cash on Hand as of December 2023 : $0.11 B
According to Aclaris Therapeutics's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aclaris Therapeutics - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -45.26% |
| 2022-12-31 | $0.21 B | 13.67% |
| 2021-12-31 | $0.19 B | 253.61% |
| 2020-12-31 | $54.13 M | -26.12% |
| 2019-12-31 | $73.26 M | -56.38% |
| 2018-12-31 | $0.16 B | -13.35% |
| 2017-12-31 | $0.19 B | 41.27% |
| 2016-12-31 | $0.13 B | 61.69% |
| 2015-12-31 | $84.86 M | 426.15% |
| 2014-12-31 | $16.13 M | 21.06% |
| 2013-12-31 | $13.32 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 74.79% | 🇺🇸 USA |